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Abstract
G protein-coupled receptors (GPCRs) mediate signaling from extracellular ligands to intracellular
signal transduction proteins1. Methuselah (Mth) is a class B (secretin-like) GPCR, a family typified
by their large, ligand-binding, N-terminal extracellular domains2. Down-regulation of mth increases
the lifespan of Drosophila melanogaster3— inhibitors of Mth signaling would thus be expected to
enhance longevity. We used mRNA display selection4,5 to identify high affinity (KD = 15 to 30 nM)
peptide ligands that bind to the N-terminal ectodomain of Mth. The selected peptides are potent
antagonists of Mth signaling, and structural studies suggest that they perturb the interface between
the Mth ecto- and transmembrane (TM) domains. Flies constitutively expressing a Mth antagonist
peptide exhibit a robust lifespan extension, suggesting that the peptides inhibit Mth signaling in
vivo. Our work thus provides novel lifespan-extending ligands for a metazoan and a general approach
for the design of modulators of this important class of GPCRs.
Because of their participation in numerous cell processes, GPCRs are the targets of
approximately half of marketed drugs, and new GPCR ligands continue to be pursued and
developed6. Naïve approaches toward GPCR ligand identification typically involve high-
throughput screening of a molecular library (102 to 105 unique members) in functional, cell-
based assays6–8. A powerful, alternative approach for the rapid isolation of novel ligands is
in vitro peptide selection using mRNA display, which allows access to very high library
complexities (>1013) in a robust format4. High affinity peptide ligands for RNA, small
molecule, and protein targets have been identified by mRNA display selection5.
The crystal structure of the hexahistidine-tagged Mth ectodomain was previously determined,
demonstrating that the mature, N-terminal extracellular domain of Mth is a stably folded,
glycosylated protein of 195 residues9. Since the ectodomains of other class B GPCRs maintain
recognition of their cognate ligands independently of their TM cores10,11, we targeted the Mth
ectodomain for in vitro selection to isolate putative modulators of Mth signaling. We expressed
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and purified a specifically biotinylated construct of the Mth ectodomain12 to avoid using the
weak hexahistidine epitope as an immobilization tag for selection13. Hence, the Mth
ectodomain was homogeneously presented, perhaps mimicking the juxtaposition of the
ectodomain and TM domain in the context of the full-length receptor.
We constructed a random, 27-mer peptide mRNA display library. After eight rounds of
selection, with the final four rounds including preclearing steps on matrix without target and
specific elution with free, non-biotinylated Mth, we obtained a final 8th round pool that
exhibited high activity for Mth and negligible non-specific binding (Fig. 1). DNA sequencing
of individual clones from the final selection round revealed a highly conserved consensus, [R/
P]xxWxxR, which we term the RWR motif (Table 1). This motif was not found in the recently
identified Mth peptide agonist, Stunted14, and the shortness of the consensus precluded any
statistically significant homology to the Drosophila proteome.
We synthesized several selected peptides for binding analysis by surface plasmon resonance
(SPR). Peptides containing the RWR motif demonstrated high affinity (KD <30 nM) to the
Mth ectodomain (Table 1). A scrambled version of the R8-12 synthetic peptide, as well as
W7A and R10A mutants of R8-14, exhibited no measurable binding by SPR at concentrations
up to 5 μM. Additionally, a fluorescently labeled analog of R8-12 was shown to bind full-
length Mth expressed in cell culture (Supp. Fig. 2). Hence, despite targeting the Mth
ectodomain, selected peptides recognize the full-length GPCR.
It is not clear why arginine and proline should be interchangeable at the first consensus position
of the RWR motif. Proline could provide a conformational anchor, whereas arginine makes
favorable electrostatic contacts that net result in two peptides with similar binding affinities to
Mth. Analysis of the amino acid types at each position in the aligned peptides also reveals
several trends dependent on whether arginine or proline is in the first position (Supp. Fig. 2
and Supp. Table 1).
In vitro competition binding studies suggest that the selected peptides share the same binding
site. Synthetic, unlabeled peptide R8-01 (10 μM) competed with radiolabeled, full-length
R8-01 and R8-04 for binding to immobilized Mth ectodomain, resulting in 96% and 94%
reductions in binding, respectively, compared to the amount bound without competitor. N-
Stunted, a 30-mer synthetic peptide previously shown to activate the Mth receptor14, also
competed for binding to the Mth ectodomain: at 30 μM, N-Stunted reduced binding of
radiolabeled R8-01 by 79% compared to binding without competitor. These results suggest
that the natural ligand binding site is an interaction “hot spot”15 and at least partially
reconstituted by the Mth ectodomain. Alternatively, allosteric competition may occur through
Mth conformational changes upon ligand binding.
We determined the crystal structure of the Mth ectodomain in complex with an RWR motif
peptide to identify the binding site. Electron density putatively corresponding to the R8-01 15-
mer peptide (Table 1) places the binding site near the C terminus of the ectodomain (Fig. 2a).
In the context of the full-length receptor, this suggests that the peptides bind at an interface
between the Mth ectodomain and extracellular loops (Fig. 2b). These results contradict the
hypothesis that the single exposed Trp residue in the Mth ectodomain is the binding site for
the natural ligand9. Further fluorescence studies with Mth, R8-01, and R8-04 confirm that
Trp120 is not required for peptide binding to Mth (Supp. Fig. 3).
The second extracellular loop (EL2) of Mth contains a WxxR peptide sequence (a partial RWR
motif), which may interact with the ectodomain in a similar fashion as the RWR motif peptides
and form a distinct surface for agonist binding (Fig. 2b). However, at concentrations of up to
150 μM, a synthetic EL2 peptide did not compete with radiolabeled R8-01. This may not
preclude an in vivo interaction since the affinity may be enhanced in the full-length receptor
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where the EL2 sequence and the ectodomain are co-localized. Additionally, a high affinity,
optimized interaction may be undesirable for the modulation of natural signaling. Indeed, the
bias of in vitro selection for high affinity ligands may favor the recovery of antagonists rather
than agonists, which are evolved for function rather than binding.
The Stunted peptide was previously identified as an agonist for Mth using a cell-based,
fluorescence reporter system for calcium mobilization, a common consequence of GPCR
activation14. We used the same technique here to determine if the selected peptides antagonize
Mth signaling. R8-12 and R8-14 were strong antagonists of N-Stunted–induced Mth signaling,
with 50% inhibitory concentration (IC50) values of 45 ± 10 and 115 ± 25 nM, respectively (Fig.
3). The W7A and R10A mutants of R8-14, as well as the R8-12 scrambled peptide, failed to
antagonize Mth at concentrations up to 10 μM. No signaling was induced by any of the peptides
in non-transfected, control HEK cells. RWR motif peptides likely antagonize Mth by blocking
interaction with agonist. However, it is also possible that the peptides desensitize the receptor
(e.g., by triggering internalization) or block GPCR oligomerization, which may be required
for proper signaling.
Since down-regulation of mth increases lifespan3, we speculated that the in vivo application of
a Mth antagonist would affect Drosophila longevity. We generated transgenic flies that
constitutively express the R8-12 peptide using the UAS/GAL4 system16. Expression of the
R8-12 peptide extended the mean and maximal adult lifespans at 29 °C by 38% and 26%,
respectively (Fig. 4a). Two other independent UAS–R8-12 insertion lines showed similar
lifespan increases (Supp Fig. 4a). F1 heterozygous lines, each carrying one of the two P-
elements (da-GAL4 or UAS–R8-12), show similar lifespans to parental controls, suggesting
that the longevity seen with peptide expression is not due to heterosis (Supp. Fig. 4b).
Additionally, expression of a mutant R8-12 peptide, where critical residues of the RWR motif
were mutated to Ala, resulted in no extension of lifespan (Fig. 4b). Male survival curves at 25
°C also show lifespan extension with R8-12 expression (Supp. Fig. 4c). These results suggest
that the expressed R8-12 peptide antagonizes Mth in vivo. However, because the role of other
Mth-like receptors in longevity is unknown, and because other Mth-like extracellular domains
share significant sequence similarity to the Mth ectodomain (up to 60% identity), the action of
the R8-12 peptide may be through other or multiple proteins. Studying the effects of R8-12
expression on other phenotypes observed in the mth mutant may reveal the relationships
between aging, synaptic transmission, and fertility 3,17–19.
In vitro selection has emerged as a powerful alternative to screening approaches for the
identification of modulators of G protein signaling20,21. Our work provides a clear strategy for
designing functional ligands for class B GPCRs, a protein family associated with a number of
human diseases2. New expression and presentation platforms for TM proteins will be needed
to broaden the utility of mRNA display selection for developing novel ligands. Selections
targeting full-length GPCRs expressed in cells remain an unattractive option due to the large
background of cell-surface proteins. The recent successes in assembling pure GPCRs in
paramagnetic proteoliposomes22 or in a reconstituted bilayer on a biosensor surface23,24 may
be favorable alternatives for presenting a TM protein for selection. The method we describe
for the identification of GPCR effectors may provide new tools applicable to aging and other
fields.
Methods
mRNA display library preparation
The initial DNA pool was generated by PCR [0.1 M initial template, 5 total cycles of PCR
amplification using Herculase DNA polymerase (Stratagene)] of the 142.1 template (5′-TTA
AAT AGC GGA TGC ACG CAG ACC GCC ACT AGT (SNN)27 CAT TGT AAT TGT AAA
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TAG TAA TTG TCC C; N = A, C, G, or T; S = C or G) with the primers 47T7FP (5′-GGA
TTC TAA TAC GAC TCA CTA TAG GGA CAA TTA CTA TTT ACA ATT AC) and 21.2
(5′-TTA AAT AGC GGA TGC ACG CAG). This library encoded a T7 promoter for
transcription, a 5′-UTR sequence, and an ORF for the peptide, M-X27-TSGGLRASAI. The
template DNA was transcribed and purified as described previously25. Cross-linking of a
puromycin-psoralen linker to the mRNA was performed as described using oligo 28A.1 (5′-
[Ps]-UAG CGG AUG C-dA16-[S9]2-dCdC-[Pu]; where unlabeled bases are 2′-OMe RNA, Ps
= psoralen C6, S9 = spacer phosphoramidite 9, and Pu = puromycin-CPG, Glen Research)26.
In vitro translation with the mRNA-28A.1 library was performed in Red Nova Lysate
(Novagen) as per the manufacturer’s instructions with optimized conditions (100 mM KOAc,
0.5 mM MgOAc, 0.4 μM mRNA-28A.1, and ~25 μM overall L-methionine; 10 ml total reaction
volume) and 35S-methionine (0.5 mCi ml−1 final). RNA-peptide fusions were salt-treated and
purified as described previously25. Fusions were reverse-transcribed (oligo 21.2) and desalted
into Mth buffer [50 mM HEPES-KOH at pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% (w/v)
BSA, 1 μg ml−1 yeast tRNA and 0.05% Tween 20] by gel filtration (NAP-25, GE Healthcare).
Based on the 35S-methionine incorporated into the RNA-peptide fusions and an average of 1.3
methionine residues per peptide, the initial complexity of the library was approximately 1.5 ×
1013.
In vitro selection
RNA:cDNA-peptide fusions were incubated with ~0.1 ml of Mth-agarose at 4 °C for 1 h, then
filtered and washed with 4 × 1 ml Mth buffer followed by 2 × 1 ml Mth buffer without BSA
or tRNA. Bound fusions were eluted with 2 × 100 μl of 0.15% SDS. After removal of the SDS
(SDS-OUT, Pierce), fusions were isopropanol-precipitated (50 μg ml−1 linear acrylamide, 1/40
volume of 3 M NaOAc at pH 5.2, and 1 volume of isopropanol). The reduced salt used for
isopropanol precipitation was necessary to prevent inhibition of subsequent PCR, due to the
high salt introduced by the SDS-OUT reagent. Precipitated cDNA was PCR-amplified to
produce a new dsDNA pool.
Further rounds of selection were performed as described for the initial round except that in
vitro translation reactions were smaller (~0.3 ml), less immobilized Mth was used for the
selective step (~20 μl), and in rounds 5 through 8, bound fusions were eluted by competition
with non-biotinylated Mth (0.5 mg ml−1) in Mth buffer without BSA or tRNA. Additionally,
rounds 5 through 8 included a preclearing step where the precipitated RNA:cDNA-peptide
fusions were passed through columns containing NeutrAvidin-agarose and/or protein G-
sepharose to remove peptides with high non-specific binding for the immobilization matrix.
Kinetics determination by surface plasmon resonance (SPR)
SPR measurements were performed at 25 °C on a BIAcore 2000 instrument equipped with
research-grade SA (streptavidin) sensor chips. Biotinylated Mth was immobilized to a surface
density of 450 to 700 response units (RU). HBS-EP [10 mM HEPES at pH 7.4, 150 mM NaCl,
3 mM EDTA, and 0.005% polysorbate 20 (Tween 20)] was used as the running buffer for all
experiments. To collect kinetics data, a concentration series of each peptide was injected for
at least 60 s at a flow rate of >45 μl min−1. Raw data was processed with Scrubber and globally
fit with CLAMP using a 1:1 bimolecular interaction model27. Sensorgrams for the R8-04
peptide are shown in Supp. Fig. 5.
Cell-based GPCR signaling assay
Calcium response assays were performed with HEK 293 cells stably expressing Mth-B
essentially as described14. Fluorescence spectra were divided by a baseline average, calculated
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from the region of data prior to the addition of N-Stunted. Further details are provided in the
Supplementary Methods online.
Lifespan assays
P-element transformants with the full-length R8-12 peptide transgene were generated in a
w1118 background by standard techniques28. R8-12Ala2 is a W5A and R8A mutant of the full-
length R8-12 sequence. UAS-controlled R8-12 lines (UAS–R8-12) were crossed with da-
GAL4, which had previously been outcrossed with w1118. F1 heterozygous adults (0–4 days
old) were transferred to new bottles, aged for 2 days, and males were separated under CO2
anesthesia (30 males per vial). After allowing the flies to recover overnight at 25 °C, flies (3–
7 days old) were incubated in a light- and humidity-controlled environment at the indicated
temperature. The UAS–R8-12 and da-GAL4 lines were each crossed with w1118 to produce
F1 heterozygous animals for controls. Flies were transferred to fresh food vials [(0.45% agar,
5% dextrose, 2.5% sucrose, 8.3% corn meal, and 1.5% dried yeast, all by weight/volume) with
phosphoric and propionic acids supplemented to prevent mold, as previously described29]
every 3–4 days and scored for survival.
Other methods
Additional methods are provided in the Supplementary Methods online.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
Selection of a 27-mer peptide library against the Mth ectodomain. RNase-treated, 35S-
methionine–labeled mRNA displayed peptides from each round of selection were assayed for
binding to immobilized Mth (black) or to matrix alone (white). Preclearing and competitive
elutions were performed in the 5th through 8th rounds to eliminate non-specific binding
peptides.
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Fig. 2.
Structure of the Mth ectodomain in complex with the R8-01 15-mer peptide. (a) Electron
density reveals the putative peptide binding site on the Mth ectodomain (shown as a ribbon
diagram) from an averaged 3.5 Å FO – FC map contoured at 9 σ. Trp120 (a previously proposed
natural ligand binding site9), Tyr130 (at the R8-01 binding site), and Asp46 and Phe153
(suggested to interact with the extracellular face of the TM domain9) are shown as stick models.
(b) Scaled model depicting the full-length structure of Mth (adapted from 9). The TM domain
is depicted by the structure of rhodopsin30 as a representative GPCR.
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Fig. 3.
RWR motif peptides are antagonists of Mth signaling. (a) Mth activation by Stunted results in
intracellular calcium mobilization and enhanced fluorescence. The N-Stunted agonist peptide
(20 μM final) was added to HEK-Mth cells pre-incubated with and without the indicated
concentration of R8-12 peptide. The dashed line indicates a control where only buffer (without
Stunted agonist) was added. (b) Concentration dependence of the inhibition of Mth signaling
by the R8-12 and R8-14 peptides. The fluorescence values at a time point ~13 sec after the
addition of N-Stunted agonist (10 μM final) are expressed as a fraction of the fluorescence
observed in the absence of antagonists (± s.d. when more than one trial was performed).
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Fig. 4.
Expression of the Mth antagonist R8-12 peptide extends fly lifespan. (a) Male lifespan for the
UAS–R8-12 transgene insertion line (41.6). (▲) Heterozygous control for the daughterless-
GAL4 driver (da-GAL4/+). (●) Heterozygous control for the UAS–R8-12 peptide construct
in the absence of the driver (UAS–R8-12/+). (■) The combination in which the da-GAL4
driver, by activating UAS promoter elements, drives expression of the R8-12 peptide (UAS–
R8-12/da-GAL4). Data are shown ± s.d. (b) Male lifespan for a mutant UAS–R8-12 transgene
(Ala2). Flies were maintained at 29 °C, and approximately 90 to 120 flies were used for each
trial.
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